Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Matthew M. Morrissette is active.

Publication


Featured researches published by Matthew M. Morrissette.


Tetrahedron Letters | 1998

THE SOLUTION PHASE SYNTHESIS OF DIKETOPIPERAZINE LIBRARIES VIA THE UGI REACTION : NOVEL APPLICATION OF ARMSTRONG'S CONVERTIBLE ISONITRILE

Christopher Hulme; Matthew M. Morrissette; Francis A. Volz; Christopher J. Burns

Abstract This communication describes the generation of high-yielding solution phase diketopiperazine libraries via a ‘3-step, 1-pot’ procedure, employing the Ugi multi-component reaction (MCR), followed by BOC deprotection and cyclization to diketopiperazine (DKP). Exploitation of Armstrongs convertible isonitrile in the Ugi reaction utilising an ‘internal nucleophile’ approach for diketopiperazine formation is presented.


Tetrahedron Letters | 1999

REMARKABLE THREE-STEP-ONE-POT SOLUTION PHASE PREPARATION OF NOVEL IMIDAZOLINES UTILIZING A UDC (UGI/DE-BOC/CYCLIZE) STRATEGY

Christopher Hulme; Liang Ma; Joseph J. Romano; Matthew M. Morrissette

Abstract This communication reveals the novel solution phase synthesis of an array of biologically relevant imidazolines in a remarkable ‘three-step-one-pot’ procedure, utilizing a Ugi/de-Boc/cyclization (UDC) strategy. Transformations are carried out in excellent yield by condensation of N -Boc-α-amino-aldehydes and supporting Ugi reagents. The described protocol represents a highly attractive solution phase procedure for the rapid generation of this class of molecule.


Angewandte Chemie | 1998

SYNTHESE VON INHIBITOREN FUR ZWEI FAMILIEN BIOLOGISCHER TARGETS IN EINER SEQUENZ : EIN NACHSTER SCHRITT BEIM AUFBAU KOMBINATORISCHER BIBLIOTHEKEN ?

Christopher J. Burns; Robert Groneberg; Joseph M. Salvino; Gerard M. McGeehan; Stephen M. Condon; Robert Morris; Matthew M. Morrissette; Rose Mathew; Shelley Darnbrough; Kent W. Neuenschwander; Anthony C. Scotese; Stevan W. Djuric; John W. Ullrich; Richard Labaudiniere

Uber nureinen Syntheseweg lassen sich Bibliotheken aus niedermolekularen Verbindungen aufbauen, die auf zwei Targetfamilien mit unterschiedlichen Funktionalitaten ausgerichtet sind. Dies wurde anhand der Entdeckung des Strukturtemplats 1 deutlich, das voneinander unabhangige pharmakophore Muster enthalt, uber die Mitglieder aus einer von zwei Targetfamilien, den Matrix-Metalloproteinasen (MMPs) oder den Phosphodiesterasen (PDEs), inhibiert werden konnen. Durch den Einbau von Bausteinen, die gegen mehrere Targets gerichtet sind, in eine Verbindungsbibliothek kann man so moglicherweise das Auffinden pharmazeutischer Leitstrukuren beschleunigen. Z=OR′ (PDE4), H (MMPs).


Journal of Medicinal Chemistry | 1999

Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an (arylsulfonyl)hydroxamic acid template.

Robert Groneberg; Christopher J. Burns; Matthew M. Morrissette; John W. Ullrich; Robert L. Morris; Shelley Darnbrough; Stevan W. Djuric; Stephen M. Condon; Gerard M. McGeehan; Richard Labaudiniere; Kent W. Neuenschwander; and Anthony C. Scotese; Jane Kline


Angewandte Chemie | 1998

Nanomolar Inhibitors for Two Distinct Biological Target Families from a Single Synthetic Sequence: A Next Step in Combinatorial Library Design?

Christopher J. Burns; Robert Groneberg; Joseph M. Salvino; Gerard M. McGeehan; Stephen M. Condon; Robert Morris; Matthew M. Morrissette; Rose Mathew; Shelley Darnbrough; Kent W. Neuenschwander; Anthony C. Scotese; Stevan W. Djuric; John W. Ullrich; Richard Labaudiniere


Journal of Medicinal Chemistry | 1996

A novel series of [2-[methyl(2-phenethyl)amino]-2-oxoethyl]benzene-containing leukotriene B4 antagonists : Initial structure-activity relationships

Fu-Chih Huang; Wan-Kit Chan; Kevin Joseph Moriarty; Gregory Bernard Poli; Matthew M. Morrissette; Robert A. Galemmo; James D. Warus; William P. Dankulich; Charles A. Sutherland


Journal of Medicinal Chemistry | 1996

Structure-activity relationships study of two series of leukotriene B4 antagonists: novel indolyl and naphthyl compounds substituted with a 2-[methyl(2-phenethyl)amino]-2-oxoethyl side chain.

Wan K. Chan; Fu-Chih Huang; Matthew M. Morrissette; James D. Warus; Kevin Joseph Moriarty; Robert A. Galemmo; William D. Dankulich; Gregory Bernard Poli; Charles A. Sutherland


Archive | 2000

A process for the preparation of N - [(aliphatic or aromatic) carbonyl] -2-aminoacetamide compounds and their cyclisation

Christopher Hulme; George C. Morton; Joseph M. Salvino; Richard Labaudiniere; Helen J. Mason; Matthew M. Morrissette; Liang Ma; Marie-P. Cherrier


Archive | 2000

Verfahren zur herstellung von n-[(aliphatisch oder aromatisch)carbonyl]-2-aminoacetamid-verbindungen und deren cyclisierung A process for the preparation of N - [(aliphatic or aromatic) carbonyl] -2-aminoacetamide compounds and their cyclisation

Marie-P. Cherrier; Christopher Hulme; Richard Labaudiniere; Liang Ma; Helen J. Mason; Matthew M. Morrissette; George C. Morton; Joseph M. Salvino


Archive | 1997

Acid compounds (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic substituted.

Christopher J. Burns; Steven M. Condon; Stevan Wakefield Djuric; Robert Groneberg; Gerard M. Mcgeehan; Matthew M. Morrissette; Kent W. Neuenschwander; Joseph M. Salvino; Anthony C. Scotese; John W. Ullrich

Collaboration


Dive into the Matthew M. Morrissette's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge